President Donald Trump’s allies are resurfacing a proposal from the first Trump administration that would dramatically cut ...
The FDA cleared the investigational new drug (IND) application for EVM14. EVM14 is an off-the-shelf tumor-associated antigen ...
EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...
Spurious drug manufacturers from other states are tarnishing the image of state’s pharmaceutical industry by using fictitious ...
The "Needle Free Drug Delivery Devices Market Industry Trends and Forecasts to 2035 -- Distribution by Type of Device, Route ...
In March 2025, Merck Sharp & Dohme LLC announced a study are to learn if people who receive V940 and pembrolizumab are alive ...
R&D innovation is likely to remain a major focus area in 2025. In the Large-Cap Pharmaceuticals industry, AbbVie (ABBV), Novo Nordisk (NVO), Novartis (NVS), Pfizer (PFE) and Bayer (BAYRY) are worth re ...
The FDA has cleared Everest Medicines’ Investigational New Drug (IND) application for EVM14, a Tumor-Associated Antigen (TAA) ...
Verve Therapeutics (VERV) announced the clearance of its Investigational New Drug application by the U.S. Food and Drug Administration for ...
Drug developers can now leverage large language models to draft regulatory documents, which they hope will shorten the time ...
Pharmaceutical Technology on MSN1d
FDA approves IND application for Everest’s cancer vaccineEVM14 is the first messenger RNA (mRNA) therapeutic vaccine developed internally by the company to gain this approval. Its ...
For some Big Pharma companies, sales in China contributed to more than 10 percent of global sales, making China a top market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback